FORT COLLINS, Colo. (PROTEXT) - Heska Corporation (Nasdaq:HSKA), a leader in the companion animal health market, announcedtoday that its PERIOceutic(TM) Gel has been approved by theEuropean Commission for marketing and distribution in Europe. Theproduct...

Zadavatel:

LONDON (PROTEXT) - New Data from a One-Year U.S. StudyReinforces European Findings ARICEPT(R) (donepezil HCl) treatment significantly extends thefunctional ability of patients with mild to moderate Alzheimer'sdisease, according to new one-year data...

Zadavatel:

PRINCETON, N.J., and TOKYO (PROTEXT) - -- Aripiprazole a Promising New Agent for Schizophrenia -- New Therapies Greatly Needed for Debilitating MentalIllness Bristol-Myers Squibb Company (NYSE: BMY) and OtsukaPharmaceutical Co., Ltd. announced today...

Zadavatel:

COLLEGEVILLE, Pa. (PROTEXT) - The following statement wasissued today by Rhone-Poulenc Rorer Pharmaceuticals: Synercid(R) (quinupristin/dalfopristin) I.V., the firstinjectable antibiotic in a distinct class of antibacterials knownas streptogramins, was...

Zadavatel:

EMERYVILLE, Calif. (PROTEXT) - Chiron Corporation (Nasdaq:CHIR) today announced that it received approval from the FrenchMinistry of Health (AFSSAPS) to market to blood banks throughoutFrance its combination nucleic acid test (NAT) to simultaneouslydetect...

Zadavatel:

REDWOOD CITY, Calif. (PROTEXT) - Genelabs Technologies, Inc.(Nasdaq: GNLB) today announced positive results of its secondPhase III clinical trial of GL701, its investigational drug forsystemic lupus erythematosus (SLE). Based on the strength ofpreliminary...

Zadavatel:

NEW YORK 21. září (PROTEXT/ots) - Lowe Healthcare Worldwide aLowe & Partners dnes oznámily, že vytvořily společný podnik,zaměřený na rychle se rozšiřující oblast marketingupředepisovaných léků přímo spotřebiteli (DTC) i na souvisejícílékařské a zdravotnické...

Zadavatel:

VÍDEŇ 17. září (PROTEXT/ots) - Údaje, které byly předloženyna Evropské konferenci o rakovině ECCO 10, ukazují, žeHerceptin(R) (účinná látka: trastuzumab) je při léčení pokročilé(metastázující) rakoviny prsu silnou a účinnou protirakovinnoulátkou. Herceptin...

Zadavatel:

Vienna, Austria (PROTEXT) - The anti-cancer drug TAXOL givenin combination with doxorubicin significantly prolongs mediantime to disease progression and survival in women with metastaticbreast cancer, according to results of a large Phase IIIinternational...

Zadavatel:

announced today an agreement to test an Eli Lilly & Company drugcandidate in XTL's proprietary animal model for hepatitis C. Theparties anticipate that XTL's technique could significantlyaccelerate the development and commercialization of...

Zadavatel:

(Amex: HEB; HEBws) today announced results of an independentevaluation of the potential pharmaco-economic benefits ofAmpligen(R) in treatment of severe Chronic FatigueSyndrome/Myalgic Encephalomyelitis (CFS/ME), including a decreasein the number of doses...

Zadavatel:

mezi Rakouskem a východní Evropou, prezentovaná profesoremChristophem Zielinským v rámci CECOG (Central EuropeanCooperative Oncology Group) VÍDEŇ 8. září (PROTEXT/ots) - Před nedávnem byla vytvořenanová společná iniciativa mezi oblastí jihovýchodní a...

Zadavatel:

Genitourinary Compound / Collaboration Between PPD and Eli LillyProves Effective Wilmington, N.C. (PROTEXT) - PPD, Inc. (Nasdaq: PPDI) todayreported on the progress of its virtual drug development servicessubsidiary, PPD GenuPro, Inc. GenuPro was established...

Zadavatel:

Injection USP Irvine, Calif. (PROTEXT) - SICOR Inc. (Nasdaq: SCRI) todayannounced that its wholly owned subsidiary, Gensia SicorPharmaceuticals, Inc., has received approval of an AbbreviatedNew Drug Application (ANDA) from the Food and Drug Administration(FDA)...

Zadavatel:

FAIRFIELD (USA) 6. září(PROTEXT/ots) - Společnost SageMaker,Inc., celosvětový poskytovatel portálů pro firemní informace(Enterprise Information Portals - EIP), dnes oznámila, žeuzavřela partnerství se společností Innaphase Corporation, kteráje předním...

Zadavatel:

Transmission Study - Potent and Affordable VIRAMUNE(R)(nevirapine) Regimen Shown to Significantly Reduce HIVTransmission - INGELHEIM, Germany (PROTEXT) - This week's issue of The Lancetfeatures encouraging preliminary results of HIVNET 012, a trialconducted...

Zadavatel:

BARCELONA (Španělsko) 1. září (PROTEXT/ots-PRNewswire) -Účinek INTEGRILINu je srovnatelný s primární cévní plastikou. Výsledky 2. fáze studie provedené na pacientech s infarktemukazují, že INTEGRILIN (R) (eptifibatide), inhibitor krevníchdestiček skupiny...

Zadavatel:

RSV in Europe / Synagis(TM) now available in Europe ABBOTT PARK, Ill., and GAITHERSBURG, Md. (PROTEXT) - AbbottLaboratories and MedImmune, Inc. today announced the EuropeanCommission granted a marketing authorization for Synagis(TM)(palivizumab) for the...

Zadavatel:

Specialist Monitoring Services (SMS) CINCINNATI (PROTEXT) - Kendle International Inc., (Nasdaq:KNDL), a leading full-service clinical development organizationheadquartered in Cincinnati, Ohio announced today the acquisitionof Specialist Monitoring Services...

Zadavatel:

Registration Statement NATICK, Mass. (PROTEXT) - Aspect Medical Systems, Inc. todayannounced that it has filed a registration statement with theSecurities and Exchange Commission for an initial public offeringof shares of its Common Stock. The shares...

Zadavatel: